4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 370, 93-105
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81570338)
- Natural Science Foundation of Jilin Province (20180101106JC)
This publication has 37 references indexed in Scilit:
- Inflammation and Oxidative Stress in Diabetic Nephropathy: New Insights on Its Inhibition as New Therapeutic TargetsJournal of Diabetes Research, 2013
- Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosisFrontiers in Endocrinology, 2013
- Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo modelsJournal of Neuroinflammation, 2012
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant MiceCell Metabolism, 2011
- tPA Activates LDL Receptor-Related Protein 1-Mediated Mitogenic Signaling Involving the p90RSK and GSK3β PathwayThe American Journal of Pathology, 2010
- Pathologic Classification of Diabetic NephropathyJournal of the American Society of Nephrology, 2010
- Renal function in diabetic nephropathyWorld Journal of Diabetes, 2010
- The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potentialBiochemical and Biophysical Research Communications, 2009
- AMP‐activated protein kinase in contraction regulation of skeletal muscle metabolism: necessary and/or sufficient?Acta Physiologica, 2009
- Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular diseaseKidney International, 2008